CVE detail

CVE-2023-41089 — CVE-2023-41089

Published 2023-10-19 · Modified 2026-06-17 · Vendor dexma · Product dexgate · Source nvd

HIGH

severity

CVSS-derived band

8.0

CVSS v3

0–10 scale

0.0052

EPSS probability

exploitation probability, 30d

41.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

The affected product is vulnerable to an improper authentication vulnerability, which may allow an attacker to impersonate a legitimate user as long as the device keeps the session active, since the attack takes advantage of the cookie header to generate "legitimate" requests.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.